Literature DB >> 8109163

Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles.

C Nicot1, T Astier-Gin, E Edouard, E Legrand, D Moynet, A Vital, D Londos-Gagliardi, J P Moreau, B Guillemain.   

Abstract

Human T-cell leukemia virus (HTLV-I) induces adult T cell leukemia/lymphoma (ATL) and a chronic neurological disease named either tropical spastic paraparesis (TSP) or HTLV-I associated myelopathy (HAM). We report here the establishment and characterization of eight HTLV-I-infected lymphoid cell lines derived either from patients with TSP (5) or from asymptomatic carriers (1). Southern blot analysis of T cell beta chain gene rearrangements indicates that all cell lines are composed of clonal populations. The same type of analysis performed with HTLV-I-specific probes showed that they harbor 1 to 5 copies of full length proviruses often associated with deleted proviruses with a restriction map for BamHI, HindIII, PstI and SacI restriction enzymes resembling those of HTLV-I previously isolated from Japan and Caribbean area. One of the cell lines, 2060, derived from a TSP patient was shown to express a relative large amount of virus easily transmissible to fresh peripheral and cord blood lymphocytes. The full length proviral genome contained in this cell line was cloned and used in transient expression experiments. We showed that the cloned provirus was able to direct the synthesis of the major structural viral proteins, the protease and the tax and rex regulatory proteins. The structural viral proteins could be assembled into free particles detected in the culture medium of transfected cells. Although the infectivity of these viral particles remains to be determined, this new clone can be employed to examine the cell types in which this TSP-derived provirus directs viral protein synthesis and eventually replicates. It should also prove of value in studies on the early cellular events induced by viral products.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8109163     DOI: 10.1016/0168-1702(93)90099-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  16 in total

1.  Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.

Authors:  Valerio W Valeri; Anna Hryniewicz; Vibeke Andresen; Kathy Jones; Claudio Fenizia; Izabela Bialuk; Hye Kyung Chung; Risaku Fukumoto; Robyn Washington Parks; Maria Grazia Ferrari; Christophe Nicot; Valentina Cecchinato; Frank Ruscetti; Genoveffa Franchini
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

2.  HTLV-I associated sicca syndrome in Guadeloupe: lack of relation with a peculiar encoding sequence of surface envelope glycoprotein.

Authors:  A Georges-Gobinet; D Moynet; C Hajjar; S Sainte-Foie; J Savin; B Guillemain
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

3.  miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

4.  Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses.

Authors:  M Kazanji; A Ureta-Vidal; S Ozden; F Tangy; B de Thoisy; L Fiette; A Talarmin; A Gessain; G de Thé
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).

Authors:  F Mortreux; M Kazanji; A S Gabet; B de Thoisy; E Wattel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.

Authors:  I Best; V Adaui; K Verdonck; E González; M Tipismana; D Clark; E Gotuzzo; G Vanham
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

7.  Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein.

Authors:  C Nicot; R Harrod
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein.

Authors:  Risaku Fukumoto; Vibeke Andresen; Izabela Bialuk; Valentina Cecchinato; Jean-Claude Walser; Valerio W Valeri; Julie M Nauroth; Antoine Gessain; Christophe Nicot; Genoveffa Franchini
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

9.  Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells.

Authors:  D Derse; J Mikovits; M Polianova; B K Felber; F Ruscetti
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

10.  PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency.

Authors:  Nga Ling Ko; John M Taylor; Marcia Bellon; Xue Tao Bai; Sergey P Shevtsov; Miroslav Dundr; Christophe Nicot
Journal:  Blood       Date:  2012-10-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.